EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Targeting Autophagy in Alzheimer's Disease: Role of the AMPK/mTOR Pathway and Drug Repurposing

Ayush Dubey iD, Ayush Chaurasia iD, Zeeshan Ansari iD, Santosh Kumar Kushwaha iD, Isha Saraf iD, Sushil Kashaw iD, Rajan Swami iD, Varun Kushwah iD

Drug Development Research · 2026-08 · 87 (5)

DOI: 10.1002/ddr.70344 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Drug Development Research, online erschienen am 08.07.2026. Verfasst von Ayush Dubey und 7 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutics and Pharmacokinetics Division, Council of Scientific and Industrial Research-Central Drug Research Institute (CSIR-CDRI), Lucknow, Utta…. Hauptthemen laut MEDLINE: Alzheimer Disease, Drug Repositioning, Autophagy, TOR Serine-Threonine Kinases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 233 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by the accumulation of amyloid‐ β (A β ) plaques and tau ( τ ) ‐related neurofibrillary tangles, often exacerbated by dysfunctional cellular clearance mechanisms. This manuscript explores the pivotal role of autophagy impairment in AD pathogenesis, with a specific focus on the AMPK/mTOR signaling axis as a primary regulatory pathway. Findings revealed that while mTOR overactivation suppresses autophagic flux and promotes the buildup of toxic protein aggregates, the activation of AMPK serves to restore homeostatic degradation processes. The review highlights that various pharmacological agent including rapamycin, metformin, trehalose, and curcumin, as well as repurposed drugs like lithium and statins can effectively enhance autophagy to ameliorate cognitive decline and neuroinflammation. Furthermore, herbal formulations such as Danggui Shaoyao San and phytoconstituents like Icariin demonstrate significant neuroprotective potential by modulating these same molecular pathways. Targeting autophagy represents a translationally viable approach for combating AD progression, with drug repurposing offering a time‐efficient and cost‐effective strategy. To advance these findings, future research should prioritize large‐scale clinical trials to validate the efficacy of autophagy‐inducing agents in human subjects. Additionally, investigating synergistic combinations of traditional bioactives with synthetic drugs and utilizing innovative delivery systems, such as intranasal nanotechnology‐based platforms to bypass the blood‐brain barrier, represents a promising frontier for developing effective, multi‐targeted treatments against AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseDrug RepositioningAutophagyTOR Serine-Threonine KinasesAMP-Activated Protein KinasesHumansSignal TransductionAnimalsNeuroprotective Agents

Stichwörter der Autor:innen

Alzheimeramyloid‐βautophagydrug repurposingmTORneurodegenerationτ protein

Substanzen

TOR Serine-Threonine KinasesAMP-Activated Protein KinasesMTOR protein, humanNeuroprotective Agents

Autor:innen und Institutionen

  • Pharmaceutics and Pharmacokinetics Division, Council of Scientific and Industrial Research-Central Drug Research Institute (CSIR-CDRI), Lucknow, Uttar Pradesh, India.
  • School of Pharmaceutical Sciences, Chhatrapati Shahu Ji Maharaj University, Kanpur, Uttar Pradesh, India.
  • Varisha Lifesciences Private Limited, Brijraj Sadan, Shiv Colony, Gwalior, Madhya Pradesh, India.
  • Varisha Pharmaceutical Reverse Engineering Private Limited, Innovation Hub, Center for Advanced Studies, Dr. A. P. J. Abdul Kalam Technical University (AKTU), Lucknow, Uttar Pradesh, India.
  • Department of Pharmaceutical Sciences, Dr. Harisingh Gour University (A Central University), Sagar, Madhya Pradesh, India.
  • Chitkara COLLege of Pharmacy, Chitkara University, Rajpura, Punjab, India.

ORCID-Profile: Ayush Dubey, Ayush Chaurasia, Zeeshan Ansari, Santosh Kumar Kushwaha, Isha Saraf, Sushil Kashaw, Rajan Swami, Varun Kushwah

Zitieren

APA

Dubey, A., Chaurasia, A., Ansari, Z., Kushwaha, S. K., Saraf, I., Kashaw, S., Swami, R., & Kushwah, V. (2026). Targeting Autophagy in Alzheimer's Disease: Role of the AMPK/mTOR Pathway and Drug Repurposing. Drug Development Research, 87(5). https://doi.org/10.1002/ddr.70344

Vancouver

Dubey A, Chaurasia A, Ansari Z, Kushwaha SK, Saraf I, Kashaw S, et al. Targeting Autophagy in Alzheimer's Disease: Role of the AMPK/mTOR Pathway and Drug Repurposing. Drug Development Research. 2026;87(5). doi:10.1002/ddr.70344

BibTeX
@article{Dubey2026,
  author = {Dubey, Ayush and Chaurasia, Ayush and Ansari, Zeeshan and Kushwaha, Santosh Kumar and Saraf, Isha and Kashaw, Sushil and Swami, Rajan and Kushwah, Varun},
  title = {Targeting Autophagy in Alzheimer's Disease: Role of the AMPK/mTOR Pathway and Drug Repurposing},
  journal = {Drug Development Research},
  year = {2026},
  volume = {87},
  number = {5},
  doi = {10.1002/ddr.70344}
}
Kostenlos starten →